The Resistive Index Is a Marker of Renal Function, Pathology, Prognosis, and Responsiveness to Steroid Therapy in Chronic Kidney Disease Patients

To evaluate the significance of the renal resistive index (RI) as a noninvasive marker of renal histological damage and a prognostic indicator, we examined RI by Doppler ultrasonography in 202 chronic kidney disease (CKD) patients who underwent renal biopsy. RI increased as the CKD stage progressed...

Full description

Saved in:
Bibliographic Details
Main Authors: Kikuno Hanamura, Akihiro Tojo, Satoshi Kinugasa, Kensuke Asaba, Toshiro Fujita
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:International Journal of Nephrology
Online Access:http://dx.doi.org/10.1155/2012/139565
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550558549934080
author Kikuno Hanamura
Akihiro Tojo
Satoshi Kinugasa
Kensuke Asaba
Toshiro Fujita
author_facet Kikuno Hanamura
Akihiro Tojo
Satoshi Kinugasa
Kensuke Asaba
Toshiro Fujita
author_sort Kikuno Hanamura
collection DOAJ
description To evaluate the significance of the renal resistive index (RI) as a noninvasive marker of renal histological damage and a prognostic indicator, we examined RI by Doppler ultrasonography in 202 chronic kidney disease (CKD) patients who underwent renal biopsy. RI increased as the CKD stage progressed and correlated with age, systolic blood pressure, estimated glomerular filtration rate (eGFR), and renal histological changes, including glomerulosclerosis, arteriolosclerosis, and tubulointerstitial damage. Prognostic evaluation with a median follow-up period of 38.5 months revealed that patients with RI≥0.7 (high RI group, n=39) had significantly poorer renal survival than those with RI<0.65 (normal RI group, n=120) and 0.65≤RI<0.7 (high-normal RI group, n=43). The patients in the high-normal RI group showed good response to steroids. However, in the high RI group, steroid therapy did not significantly improve renal survival. Of the clinical indices studied, RI≥0.7, hypertension, proteinuria, and low eGFR at diagnosis were independent risk factors for worsening renal dysfunction. In conclusion, RI in CKD patients was considered as a marker of renal function, histological damage, and renal prognosis, and a possible determinant of indication for steroids.
format Article
id doaj-art-676d1d3478d24c79b90e8eba62e45a2d
institution Kabale University
issn 2090-214X
2090-2158
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series International Journal of Nephrology
spelling doaj-art-676d1d3478d24c79b90e8eba62e45a2d2025-02-03T06:06:23ZengWileyInternational Journal of Nephrology2090-214X2090-21582012-01-01201210.1155/2012/139565139565The Resistive Index Is a Marker of Renal Function, Pathology, Prognosis, and Responsiveness to Steroid Therapy in Chronic Kidney Disease PatientsKikuno Hanamura0Akihiro Tojo1Satoshi Kinugasa2Kensuke Asaba3Toshiro Fujita4Division of Nephrology and Endocrinology, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, JapanDivision of Nephrology and Endocrinology, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, JapanDivision of Nephrology and Endocrinology, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, JapanDivision of Nephrology and Endocrinology, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, JapanDivision of Nephrology and Endocrinology, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, JapanTo evaluate the significance of the renal resistive index (RI) as a noninvasive marker of renal histological damage and a prognostic indicator, we examined RI by Doppler ultrasonography in 202 chronic kidney disease (CKD) patients who underwent renal biopsy. RI increased as the CKD stage progressed and correlated with age, systolic blood pressure, estimated glomerular filtration rate (eGFR), and renal histological changes, including glomerulosclerosis, arteriolosclerosis, and tubulointerstitial damage. Prognostic evaluation with a median follow-up period of 38.5 months revealed that patients with RI≥0.7 (high RI group, n=39) had significantly poorer renal survival than those with RI<0.65 (normal RI group, n=120) and 0.65≤RI<0.7 (high-normal RI group, n=43). The patients in the high-normal RI group showed good response to steroids. However, in the high RI group, steroid therapy did not significantly improve renal survival. Of the clinical indices studied, RI≥0.7, hypertension, proteinuria, and low eGFR at diagnosis were independent risk factors for worsening renal dysfunction. In conclusion, RI in CKD patients was considered as a marker of renal function, histological damage, and renal prognosis, and a possible determinant of indication for steroids.http://dx.doi.org/10.1155/2012/139565
spellingShingle Kikuno Hanamura
Akihiro Tojo
Satoshi Kinugasa
Kensuke Asaba
Toshiro Fujita
The Resistive Index Is a Marker of Renal Function, Pathology, Prognosis, and Responsiveness to Steroid Therapy in Chronic Kidney Disease Patients
International Journal of Nephrology
title The Resistive Index Is a Marker of Renal Function, Pathology, Prognosis, and Responsiveness to Steroid Therapy in Chronic Kidney Disease Patients
title_full The Resistive Index Is a Marker of Renal Function, Pathology, Prognosis, and Responsiveness to Steroid Therapy in Chronic Kidney Disease Patients
title_fullStr The Resistive Index Is a Marker of Renal Function, Pathology, Prognosis, and Responsiveness to Steroid Therapy in Chronic Kidney Disease Patients
title_full_unstemmed The Resistive Index Is a Marker of Renal Function, Pathology, Prognosis, and Responsiveness to Steroid Therapy in Chronic Kidney Disease Patients
title_short The Resistive Index Is a Marker of Renal Function, Pathology, Prognosis, and Responsiveness to Steroid Therapy in Chronic Kidney Disease Patients
title_sort resistive index is a marker of renal function pathology prognosis and responsiveness to steroid therapy in chronic kidney disease patients
url http://dx.doi.org/10.1155/2012/139565
work_keys_str_mv AT kikunohanamura theresistiveindexisamarkerofrenalfunctionpathologyprognosisandresponsivenesstosteroidtherapyinchronickidneydiseasepatients
AT akihirotojo theresistiveindexisamarkerofrenalfunctionpathologyprognosisandresponsivenesstosteroidtherapyinchronickidneydiseasepatients
AT satoshikinugasa theresistiveindexisamarkerofrenalfunctionpathologyprognosisandresponsivenesstosteroidtherapyinchronickidneydiseasepatients
AT kensukeasaba theresistiveindexisamarkerofrenalfunctionpathologyprognosisandresponsivenesstosteroidtherapyinchronickidneydiseasepatients
AT toshirofujita theresistiveindexisamarkerofrenalfunctionpathologyprognosisandresponsivenesstosteroidtherapyinchronickidneydiseasepatients
AT kikunohanamura resistiveindexisamarkerofrenalfunctionpathologyprognosisandresponsivenesstosteroidtherapyinchronickidneydiseasepatients
AT akihirotojo resistiveindexisamarkerofrenalfunctionpathologyprognosisandresponsivenesstosteroidtherapyinchronickidneydiseasepatients
AT satoshikinugasa resistiveindexisamarkerofrenalfunctionpathologyprognosisandresponsivenesstosteroidtherapyinchronickidneydiseasepatients
AT kensukeasaba resistiveindexisamarkerofrenalfunctionpathologyprognosisandresponsivenesstosteroidtherapyinchronickidneydiseasepatients
AT toshirofujita resistiveindexisamarkerofrenalfunctionpathologyprognosisandresponsivenesstosteroidtherapyinchronickidneydiseasepatients